Home/Filings/4/0001181431-13-015379
4//SEC Filing

YACHMETZ PHILIP K 4

Accession 0001181431-13-015379

CIK 0000722104other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:50 PM ET

Size

7.4 KB

Accession

0001181431-13-015379

Insider Transaction Report

Form 4
Period: 2013-03-05
YACHMETZ PHILIP K
SVP, General Counsel
Transactions
  • Award

    Option to Purchase Common Stock

    2013-03-05+110,000110,000 total
    Exercise: $0.94Exp: 2023-03-05Common Stock (110,000 underlying)
  • Award

    Option to Purchase Common Stock

    2013-03-05+78,00078,000 total
    Exercise: $2.26Exp: 2022-02-01Common Stock (78,000 underlying)
Footnotes (2)
  • [F1]These options will vest in proportional 25% increments on each of the first four anniversaries of the grant date, March 5, 2013.
  • [F2]These options reflect the vesting of performance options that were granted to the reporting person effective February 1, 2012.

Issuer

SAVIENT PHARMACEUTICALS INC

CIK 0000722104

Entity typeother

Related Parties

1
  • filerCIK 0001250318

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:50 PM ET
Size
7.4 KB